Silence Therapeutics Plc (SLNCF)
2.600
+0.60
(+30.00%)
USD |
OTCM |
Apr 10, 14:04
Silence Therapeutics EPS Diluted (Quarterly) : -0.0831 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Adaptimmune Therapeutics Plc | -0.1163 |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | -0.7979 |
| Autolus Therapeutics Plc | -0.3389 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.77M |
| Revenue (Quarterly) | 0.034M |
| Total Expenses (Quarterly) | 11.80M |
| Enterprise Value | 198.45M |
| Gross Profit Margin (Quarterly) | -232.4% |
| Profit Margin (Quarterly) | -34.62K% |
| Earnings Yield | -24.05% |
| Normalized Earnings Yield | -23.80 |